Osteoarthritis

Diagnosis and Management of Lameness in the Horse

Volumn , Issue , 2003, Pages 572-591

  Caron, John P ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645947111     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-8342-3.50070-X     Document Type: Chapter

References (276)

1. Mankin HJ, Radin EL Structure and function of joints. Arthritis and allied conditions: a textbook of rheumatology 1997, 1. Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
2. Sledge CB, Hari Reddi A, Walsh DA, et al. Biology of the normal joint. Textbook of rheumatology 2001, 1. WB Saunders, Philadelphia. ed 6. S. Ruddy, E.D. Harris, C.B. Sledge (Eds.).
3. Todhunter RJ, Lust G Pathophysiology of synovitis: clinical signs and examination in horses. Comp Cont Educ Pract Vet 1990, 12:980.
4. Rossdale PD, Hopes R, Wingfield-Digby NJ, et al. Epidemiological study of wastage among racehorses, 1982 and 1983. Vet Rec 1985, 116:66.
5. Jeffcott LB, Rossdale PD, Freestone J, et al. An assessment of wastage in thoroughbred racing from conception to 4 years of age. Equine Vet J 1982, 14:185.
6. Bassleer R, Lhoest-Ganthier MP, Renard AM, et al. Histological structure and functions of synovium. Articular synovium 1982, Karger, Basel, Switzerland. P. Franchimont (Ed.).
7. Ghadially FN, Roy S Ultrastructure of synovial joints in health and disease 1969, Butterworth, London.
8. Stevens CR, Mapp PI, Revell PA A monoclonal antibody (Mab 67) marks type B synoviocytes. Rheumatol Int 1990, 10:103.
9. Krey PR, Cohen AS, Smith CB, et al. The human fetal synovium: histology, fine structure and changes in organ culture. Arthritis Rheum 1971, 114:319.
10. Graabaek PM Ultrastructural evidence for two distinct types of synoviocytes in rat synovial membrane. J Ultrastruc Res 1982, 78:321.
11. Wilkinson LS, Pitsillides AA, Worrall JG, et al. Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum 1992, 35:1179.
12. Gadher SJ, Woolley DE Comparative studies of adherent rheumatoid synovial cells in primary culture: characterisation of the dendritic (stellate) cell. Rheumatol Int 1987, 7:13.
13. Henderson B, Pettipher ER The synovial lining cell: biology and pathobiology. Semin Arthritis Rheum 1985, 15:1.
14. Roy S, Ghadially FN, Crane WA J Synovial membrane in traumatic effusion: ultrastructure and autoradiography with tritiated leucine. Ann Rheum Dis 1966, 25:259.
15. Norton WL, Lewis DC, Ziff M Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis Rheum 1968, 11:436.
16. Müller-Ladner U, Gay RE, Gay S Structure and function of synoviocytes. Arthritis and allied conditions: a textbook of rheumatology 1997, 1. Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
17. Danis VA, March LM, Nelson DS, et al. Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 1987, 14:33.
18. Guerne PA, Zuraw BL, Vaughan JH, et al. Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 1989, 83:585.
19. Bathon JM, Chilton FH, Hubbard WC, et al. Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism. Inflammation 1996, 20:537.
20. Landoni MF, Foot R, Frean S, et al. Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation. Equine Vet J 1996, 28:468.
21. Martel-Pelletier J, Cloutier JM, Pelletier JP Neutral proteases in human osteoarthritic synovium. Arthritis Rheum 1986, 29:1112.
22. Canoso J Bursae, tendons and ligaments. Clin Rheum Dis 1981, 7:189.
23. Gamble JG, Edwards CC, Max SR Enzymatic adaptation in ligaments during immobilization. Am J Sports Med 1984, 12:221.
24. Grana WA, Larson RL Functional and surgical anatomy. The knee: form, function, pathology, treatment 1993, WB Saunders, Philadelphia. R.L. Larson, W.A. Grana (Eds.).
25. Hvid I Mechanical strength of trabecular bone at the knee. Dan Med Bull 1988, 35:345.
26. Simkin PA, Heston TF, Downey DJ, et al. Subchondral architecture in bones of the canine shoulder. J Anat 1991, 175:213.
27. Oettmeier R, Arokoski J, Roth AJ, et al. Quantitative study of articular cartilage and subchondral bone remodeling in the knee joint of dogs after strenuous running training. J Bone Miner Res 1992, 7(2):S419.
28. Radin EL, Rose RM Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986, 213:34.
29. Dequeker J, Mokassa L, Aerssens J Bone density and osteoarthritis. J Rheumatol 1995, 43:98.
30. Redler I, Mow VC, Zimny ML, et al. The ultrastructure and biomechanical significance of the tidemark of articular cartilage. Clin Orthop 1975, 112:357.
31. Mankin HJ, Thrasher AZ Water content and binding in normal and osteoarthritic human cartilage. J Bone Joint Surg Am 1975, 57:76.
32. Mayne R, Irwin MH Collagen types in cartilage. Articular cartilage biochemistry 1986, Raven Press, New York. K.E. Kuettner, R. Schleyerbach, V.C. Hascall (Eds.).
33. Eyre DR The collagens of articular cartilage. Semin Arthritis Rheum 1991, 21(2):2.
34. Bruckner P, van der Rest M Structure and function of cartilage collagens. Microsc Res Tech 1994, 28:378.
35. Vachon AM, Keeley FW, McIlwraith CW, et al. Biochemical analysis of normal articular cartilage in horses. Am J Vet Res 1990, 51:1905.
36. Mankin HJ, Brandt KD Pathogenesis of osteoarthritis. Textbook of rheumatology 2001, 1. WB Saunders, Philadelphia. ed 6. S. Ruddy, E.D. Harris, C.B. Sledge (Eds.).
37. Todhunter RJ, Wootton JA, Lust G, et al. Structure of equine type I and type II collagens. Am J Vet Res 1994, 55:425.
38. Eyre DR, Paz MA, Gallop PM Cross-linking in collagen and elastin. Annu Rev Biochem 1984, 53:717.
39. Schenk RK, Eggli PS, Hunziker EB Articular cartilage morphology. Articular cartilage biochemistry 1986, Raven Press, New York. K.E. Kuettner (Ed.).
40. Repo RU, Mitchell N Collagen synthesis in mature articular cartilage of the rabbit. J Bone Joint Surg Br 1971, 53:541.
41. Eyre DR, McDevitt CA, Billingham ME J, et al. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 1980, 188:823.
42. Li Y, Lacerda DA, Warman ML, et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell 1995, 80:423.
43. Stallcup WB, Dahline K, Healy P Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J Cell Biol 1990, 111:3177.
44. Kielty CM, Whittaker SP, Grant ME, et al. Type VI collagen microfibrils: evidence for a structural association with hyalurona. J Cell Biol 1992, 118:979.
45. Wu JJ, Woods PE, Eyre DR Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J Biol Chem 1992, 267:23007.
46. Sandy JD, Plaas AH K, Rosenberg L Structure, function and metabolism of cartilage proteoglycans. Arthritis and allied conditions: a textbook of rheumatology 1997, 1. Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
47. Poole AR, Reiner A, Tang LH, et al. Proteoglycans from bovine nasal cartilage: immunochemical studies of link protein. J Biol Chem 1980, 255:9295.
48. Dudhia J, Platt D Complete primary sequence of equine cartilage link protein deduced from complementary DNA. Am J Vet Res 1995, 56:959.
49. Flannery C, Stanescu V, Morgelin M, et al. Variability in the G3 domain content of bovine aggrecan from cartilage extracts and chondrocyte cultures. Arch Biochem Biophys 1992, 297:52.
50. Mehmet H, Scudder P, Tang PW, et al. The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta or larger oligosaccharides of the poly-(N-acetyllactosamine) series. Eur J Biochem 1986, 157:385.
51. Poole AR Proteoglycans in health and disease: structures and functions. Biochem J 1986, 236:1.
52. Poole AR Cartilage in health and disease. Arthritis and allied conditions: a textbook of rheumatology 1997, 1. Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
53. Scott JE Proteoglycan-fibrillar collagen interactions. Biochem J 1988, 252:313.
54. Noyori K, Jasin HE Inhibition of human fibroblast adhesion by cartilage surface proteoglycans. Arthritis Rheum 1994, 37:1656.
55. Bidanset DJ, LeBaron R, Rosenberg L, et al. Regulation of cell substrate adhesion: effects of small galactosaminoglycan-containing proteoglycans. J Cell Biol 1992, 118:1523.
56. Heinegard D, Lorenzo P, Sommarin Y Articular cartilage matrix proteins. Osteoarthritic disorders 1995, American Academy of Orthopaedic Surgeons, Rosemont, IL. K.E. Kuettner, V.M. Goldberg (Eds.).
57. Thonar EJ-MA, Masuda K, Manicourt DH, Kuettner KE Structure and function of normal adult articular cartilage. Osteoarthritis: clinical and experimental aspects 1999, Springer, Berlin. J.-Y. Reginster, J.-P. Pelletier, J. Martel-Pelletier (Eds.).
58. Burton-Wurster N, Lust G Deposition of fibronectin in articular cartilage of canine osteoarthritic joints. Am J Vet Res 1985, 46:2542.
59. Homandberg GA, Meyers R, Xie D Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992, 267:359.
60. Repo RU, Mitchell N Collagen synthesis in mature articular cartilage of the rabbit. J Bone Joint Surg Br 1971, 53:541.
61. Eyre DR, McDevitt CA, Billingham ME J, et al. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 1980, 188:823.
62. Lohmander LS, Kimura JH Biosynthesis of cartilage proteoglycan. Articular cartilage biochemistry 1986, Raven Press, New York. K.E. Kuettner, R. Schleyerbach, V.C. Hascall (Eds.).
63. Palmoski MJ, Brandt KD Effects of static loading and cyclic compressive loading on articular cartilage plugs in vitro. Arthritis Rheum 1984, 27:675.
64. Schneiderman R, Keret D, Maroudas A Effect of mechanical and osmotic pressure on the rate of glycosaminoglycan synthesis in the human adult femoral head cartilage: an in vitro study. J Orthop Res 1986, 4:393.
65. Pita J, Howell D Micro-biochemical studies of cartilage. The joints and synovial fluid 1978, Academic Press, New York. L. Sokoloff (Ed.).
66. Maroudas A, Bullough P, Swanson SA, et al. The permeability of articular cartilage. J Bone Joint Surg Br 1968, 50:166.
67. Hadler N The biology of the extracellular space. Clin Rheum Dis 1981, 7:71.
68. Setton LA, Mow VC, Muller FJ, et al. Mechanical behavior and biochemical composition of canine knee cartilage following periods of joint disuse and disuse with remobilization. Osteoarthritis Cartilage 1997, 5:1.
69. Swanson SA V Lubrication. Adult articular cartilage 1979, Pitman Medical, Kent, England. M.A. R. Freeman (Ed.).
70. Mow VC, Mansour JM The nonlinear interaction between cartilage deformation and interstitial fluid flow. J Biomech 1977, 10:1.
71. Swann DA, Radin EL The molecular basis of articular lubrication. I. Purification and properties of a lubricating fraction from bovine synovial fluid. J Biochem 1972, 274:8069.
72. Radin EL, Swann DA, Weisser PA Separation of a hyaluronate free lubricating fraction from synovial fluid. Nature 1970, 228:377.
73. Linn FC, Radin EL Lubrication of animal joints. III. The effect of certain chemical alterations of the cartilage and lubricant. Arthritis Rheum 1968, 11:674.
74. Roberts BJ, Unsworth A, Main N Modes of lubrication in human hip joints. Ann Rheum Dis 1982, 41:217.
75. Mabuchi K, Tsukamoto Y, Obara T, et al. The effect of additive hyaluronic acid on animal joints with experimentally reduced lubricating ability. J Biomed Maters Res 1994, 28:865.
76. Johns RJ, Wright V Relative importance of various tissues in joint stiffness. J Appl Physiol 1962, 17:824.
77. Swann DA, Radin EL, Nazimiec M, et al. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis 1974, 33:318.
78. Schwarz N, Leixnering M, Hopf R, et al. Pressurevolume ratio in human cadaver hip joints. Arch Orthop Trauma Surg 1988, 107:322.
79. Pedowitz RA, Gershuni DH, Crenshaw AG, et al. Intraarticular pressure during continuous passive motion of the human knee. J Orthop Res 1989, 7:530.
80. O'Connor J, Shercliff T, Goodfellow J The mechanics of the knee in sagittal planes: mechanical interactions between muscles, ligaments and articular surfaces. Surgery and arthroscopy of the knee 1988, Springer-Verlag, New York. W. Mueller, W. Hackenbruck (Eds.).
81. Funk DA, Noyes FR, Grood ES, et al. Effect of flexion angle on the pressure-volume of the human knee. Arthroscopy 1991, 7:86.
82. Hardy J, Bertone AL, Muir WW Pressure-volume relationships in equine midcarpal joint. J Appl Physiol 1995, 78:1977.
83. Myers DE, Palmer DG Capsular compliance and pressure-volume relationships in normal and arthritic knees. J Bone Joint Surg Br 1972, 54:710.
84. Levick JR Joint pressure-volume studies: their importance, design and interpretation. J Rheumatol 1983, 10:353.
85. Strand E, Martin GS, Crawford MP, et al. Intra-articular pressure, elastance, and range of motion in flexion of the equine metacarpophalangeal joint. Am J Vet Res 1995, 56:1362.
86. Kumar VP, Balasubramaniam P The role of atmospheric pressure in stabilising the shoulder: an experimental study. J Bone Joint Surg Br 1985, 67:719.
87. Huberti HH, Hayes WC Patellofemoral contact pressures: the influence of the Q-angle and tendofemoral contact. J Bone Joint Surg Am 1984, 66:715.
88. Simon SR, Paul IL, Mansour J, et al. Peak dynamic force in human gait. J Biomech 1981, 14:817.
89. Sledge CB Biology of the joint. Textbook of rheumatology 1993, WB Saunders, Philadelphia. ed 4. W.N. Kelley, E.D. Harris, S. Ruddy (Eds.).
90. Mow VC, Kuei SC, Lai WM, et al. Biphasic creep and stress relaxation of articular cartilage in compression: theory and experiments. J Biomech Eng 1980, 102:73.
91. Kempson GE Mechanical properties of articular cartilage. Adult articular cartilage 1979, Pitman Medical, Kent, England. M.A. R. Freeman (Ed.).
92. Schmidt MB, Mow VC, Chun LE, et al. Effects of proteoglycan extraction on the mechanical properties of adult human articular cartilage. J Orthop Res 1990, 8:353.
93. Harris ED, DiBona DR, Krane SM A mechanism for cartilage destruction in rheumatoid arthritis. Trans Assoc Am Phys 1970, 83:267.
94. Harris ED, Parker HG, Radin EL, et al. Effects of proteolytic enzymes on structural and mechanical properties of cartilage. Arthritis Rheum 1972, 15:497.
95. Armstrong CG, Gardner DL Thickness and distribution of human femoral head articular cartilage. Ann Rheum Dis 1977, 36:407.
96. Radin EL, All IL Does cartilage compliance reduce skeletal impact loads? The relative force-attenuating properties of articular cartilages, synovial fluid, periarticular soft tissues in bone. Arthritis Rheum 1970, 13:139.
97. Ochoa JA, Heck DA, Brandt KD, et al. The effect of intertrabecular fluid on femoral head mechanics. J Rheumatol 1991, 18:580.
98. Pugh JW, Rose RM, Radin EL A possible mechanism of Wolff's law: trabecular microfractures. Arch Int Physiol Biochim 1973, 81:27.
99. Ito H, Nagasaki H, Hashizume K, et al. Time-course of force production by fast isometric contraction of the knee extensor in young and elderly subjects. J Hum Ergol 1990, 19:23.
100. Hough AJ Pathology of osteoarthritis. Arthritis and allied conditions: a textbook of rheumatology 1997, 2. Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
101. Katzenstein PL, Malemud CJ, Pathria MN, et al. Early onset primary osteoarthritis and mild chondrodysplasia: radiographic and pathologic studies with an analysis of cartilage proteoglycans. Arthritis Rheum 1990, 33:674.
102. Knowlton RG, Katzenstein PL, Moskowitz RW, et al. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med 1990, 322:526.
103. Norrdin RW, Kawcak CE, Capwell BA, et al. Subchondral bone failure in an equine model of overload arthrosis. Bone 1998, 22:133.
104. Benske J, Schunke M, Tillman B Subchondral bone formation in arthrosis: polychrome labeling studies in mice. Acta Orthop Scand 1988, 59:536.
105. Brown TD, Radin EL, Martin RB, et al. Finite element studies of some juxtarticular stress changes due to localized subchondral bone stiffening. J Biomech 1984, 17:11.
106. Dedrick DK, Goldstein SA, Brandt KD, et al. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months. Arthritis Rheum 1993, 36:1460.
107. Mow VC, Ratcliffe A, Poole AR Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 1992, 13:67.
108. Alaaeddine N, DiBattista JA, Pelletier JP, et al. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J Rheumatol 1997, 24:1985.
109. Bathon JM, Chilton FH, Hubbard WC, et al. Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism. Inflammation 1996, 20:537.
110. May SA, Hooke RE, Lees P Bone fragments stimulate equine synovial lining cells to produce the inflammatory mediator prostaglandin E2. Equine Vet J Suppl 1988, 6:131.
111. May SA, Hooke RE, Lees P Interleukin-1 stimulation of equine articular cells. Res Vet Sci 1992, 52:342.
112. Farahat MN, Yanni G, Poston R, et al. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993, 52:870.
113. Pelletier JP, McCollum R, Cloutier JM, et al. Synthesis of metalloproteases and interleukin-6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 1991, 43:109.
114. Fujikawa Y, Shingu M, Torisu T, et al. Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995, 54:318.
115. Spiers S, May SA, Bennett D, et al. Cellular sources of proteolytic enzymes in equine joints. Equine Vet J 1994, 26:43.
116. Clegg PD, Burke RM, Coughlan AR, et al. Characterization of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Equine Vet J 1997, 29:335.
117. Gibson KT, Hodge H, Whittem T Inflammatory mediators in equine synovial fluid. Aust Vet J 1996, 73:148.
118. Auer DE, Ng JC, Seawright AA Free radical oxidation products in plasma and synovial fluid of horses with synovial inflammation. Aust Vet J 1993, 70:49.
119. Alwan WH, Carter SD, Dixon JB Interleukin-1-like activity in synovial fluids and sera of horses with arthritis. Res Vet Sci 1991, 51:72.
120. Morris EA, McDonald BS, Webb AC Identification of interleukin-1 in equine osteoarthritic joint effusions. Am J Vet Res 1990, 51:59.
121. Niebauer GW, Wolf B, Yarmush M, et al. Evaluation of immune complexes and collagen type-specific antibodies in sera and synovial fluids of horses with secondary osteoarthritis. Am J Vet Res 1988, 49:1223.
122. Caron JP, Bowker RM, Abhold RH, et al. Substance P in the synovial membrane and fluid of the equine middle carpal joint. Equine Vet J 1992, 24:364.
123. Owens JG, Kamerling SG, Stanton SR, et al. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. Am J Vet Res 1996, 57:866.
124. Hawkins DL, Cargile JL, MacKay RJ, et al. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Am J Vet Res 1995, 56:1292.
125. Sabiston CP, Adams ME Production of catabolin by synovium from an experimental model of osteoarthritis. J Orthop Res 1989, 7:519.
126. Vankemmelbeke MN, Ilic MZ, Handley CJ, et al. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity. Biochem Biophys Res Commun 1999, 255:686.
127. Platt D Articular cartilage homeostasis and the role of growth factors and cytokines in regulating matrix composition. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
128. Rizkalla G, Bogoch ER, Poole AR Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 1992, 90:2268.
129. Mankin HJ, Lippielo L The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest 1971, 50:1712.
130. Curtin WA, Reville WJ Ultrastructural observations on fibril profiles in normal and degenerative human articular cartilage. Clin Orthop 1995, 313:224.
131. Altman RD, Tenenbaum J, Latta L, et al. Biomechanical and biochemical properties of dog cartilage in experimentally induced osteoarthritis. Ann Rheum Dis 1984, 43:83.
132. Maroudas A, Ziv I, Weisman N, et al. Studies of hydration and swelling pressure in normal and osteoarthritic cartilage. Biorheology 1985, 22:159.
133. Shingu M, Isayama T, Yasutake C, et al. Role of oxygen radicals and IL-6-dependent matrix degradation. Inflammation 1994, 18:613.
134. Katrantzis M, Baker MS, Handley CJ, et al. The oxidant hypochlorite (OCl-), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate. Free Radic Biol Med 1991, 10:101.
135. Henrotin Y, Deby Dupont G, Deby C, et al. Production of active oxygen species by isolated human chondrocytes. Br J Rheumatol 1993, 32:562.
136. Roberts CR, Roughley PJ, Mort JS Degradation of human proteoglycan aggregate induced by hydrogen peroxide: protein fragmentation, amino acid modification and hyaluronic acid cleavage. Biochem J 1989, 259:805.
137. Nagase J, Woessner JF Role of endogenous proteinases in the degradation of cartilage matrix. Joint cartilage degradation: basic and clinical aspects 1993, Marcel Dekker, New York. J.F. Woessner, D.S. Howell (Eds.).
138. Werb Z, Alexander CM Proteinases in matrix degradation. Textbook of rheumatology 1993, 1. WB Saunders, Philadelphia. ed 4. W.N. Elli, E.D. Harris, S. Ruddy (Eds.).
139. Little CB, Flannery CR, Hughes CE, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999, 344(1):161.
140. Campbell IK, Golds E, Mort JS, et al. Human articular cartilage secretes characteristic metal dependent proteinases upon stimulation by mononuclear cell factor. J Rheumatol 1986, 21:20.
141. Nagase H, Brinckerhoff CE, Vater CA, et al. Biosynthesis and secretion of procollagenase by rabbit synovial fibroblasts: inhibition of procollagenase secretion by monensin and evidence for glycosylation of procollagenase. Biochem J 1983, 214:281.
142. Okada Y Proteinases and matrix degradation. Textbook of rheumatology 2001, 1. WB Saunders, Philadelphia. ed 6. S. Ruddy, E.D. Harris, C.B. Sledge (Eds.).
143. Dean DD Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 1991, 20:2.
144. Okada Y, Shinmmei M, Tanaka O, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992, 66:680.
145. Pelletier JP, Mineau F, Woessner JF, et al. Intraarticular injection with methyl prednisolone acetate reduces osteoarthritis lesions at the same time as chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994, 37:414.
146. Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor (TIMP) imbalance in human osteoarthritic cartilage. J Clin Invest 1989, 84:678.
147. McKie N, Edwards T, Dallas DJ, et al. Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes. Biochem Biophys Res Commun 1997, 230:335.
148. Flannery CR, Little CB, Caterson B, et al. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes. Matrix Biol 1999, 18:225.
149. Arner EC, Pratta MA, Trzaskos JM, et al. Generation and characterization of aggrecanase: a soluble, cartilagederived aggrecan-degrading activity. J Biol Chem 1999, 274:6594.
150. Tortorella MD, Burn TC, Pratta MA, et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284:1664.
151. Abbaszade I, Liu RQ, Yang F, et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999, 274:23443.
152. Tortorella M, Pratta M, Liu RQ, et al. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem 2000, 275:25791.
153. Yamada H, Nakagawa T, Stephens RW, et al. Proteinases and their inhibitors in normal and osteoarthritic articular cartilage. Biomed Res 1987, 8:289.
154. Murphy G, Willenbrock R Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol 1995, 248:496.
155. McCachren SS Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991, 34:1085.
156. Zafarullah M, Su S, Martel-Pelletier J, et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal, and osteoarthritic articular chondrocytes. J Cell Biochem 1996, 60:211.
157. Su S, Grover J, Roughley PJ, et al. Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int 1999, 18:183.
158. Martel-Pelletier J, McCollum R, Fujimoto N, et al. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994, 70:807.
159. Towle CA, Hung HH, Bonassar LJ, et al. Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. Osteoarthritis Cartilage 1997, 5:293.
160. Ounissi-Benkalha H, Pelletier JP, Tardif G, et al. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis. J Rheumatol 1996, 23:16.
161. Westacott CI, Atkins RM, Dieppe PA, et al. Tumor necrosis factor-+ receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol 1994, 21:1710.
162. Martel-Pelletier J, McCollum R, DiBattista J, et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Arthritis Rheum 1992, 35:530.
163. Fell HB, Jubb R The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum 1977, 20:1371.
164. May SA, Hooke RE, Lees P Interleukin-1 stimulation of equine articular cells. Res Vet Sci 1992, 52:342.
165. Tyler JA, Benton HP Synthesis of type II collagen is decreased in cartilage cultured with interleukin-1 while the rate of extracellular degradation remains unchanged. Coll Relat Res 1988, 8:393.
166. Arner EC, Pratta MA Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum 1989, 32:288.
167. Murphy G, Hembry RM, Reynolds JJ Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Relat Res 1986, 6:351.
168. Platt D, Bayliss MT An investigation of the proteoglycan metabolism of mature equine articular cartilage and its regulation by interleukin-1. Equine Vet J 1994, 26:297.
169. Morris EA, Treadwell BV Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage. Am J Vet Res 1994, 55:138.
170. Caron JP, Tardif G, Martel-Pelletier J, et al. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res 1996, 57:1631.
171. MacDonald MH, Stover SM, Willits NH, et al. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1. Am J Vet Res 1992, 53:2278.
172. Richardson DW, Dodge GR Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes. Am J Vet Res 2000, 61:624.
173. Richardson DW, Dodge GR Cloning of equine type II procollagen and the modulation of its expression in cultured equine articular chondrocytes. Matrix Biol 1997, 16:59.
174. Goldring MB, Birkhead J, Sandell LJ, et al. Interleukin-1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 1988, 82:2026.
175. Martel-Pelletier J, Zafarullah M, Kodama S, et al. In vitro effects of interleukin-1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors inhuman articular cartilage. J Rheumatol 1991, 27:80.
176. Bathon JM, Chilton FH, Hubbard WC, et al. Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism. Inflammation 1996, 20:537.
177. Bandara G, Georgescu HI, Lin CW, et al. Synovial activation of chondrocytes: evidence for complex cytokine interactions. Agents Actions 1991, 34:285.
178. Stefanovich-Racic M, Stadler J, Evans CH Nitric oxide and arthritis. Arthritis Rheum 1993, 36:1036.
179. Evans CH, Stefanovic-Racic M, Lancaster J Nitric oxide and its role in orthopaedic disease. Clin Orthop 1995, 312:275.
180. Frean SP, Bryant CE, Froling IL, et al. Nitric oxide production by equine articular cells in vitro. Equine Vet J 1997, 29:98.
181. Bunning RA, Richardson HJ, Crawford A, et al. The effect of interleukin-1 on connective tissue metabolism and its relevance to arthritis. Agents Actions 1986, 18:131.
182. Hung GL, Galea-Lauri J, Mueller GM, et al. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1994, 1:64.
183. Caron JP, Fernandez JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996, 39:1535.
184. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997, 40:1012.
185. Hawkins DL, MacKay RJ, Gum GG, et al. Effects of intra-articularly administered endotoxin on clinical signs of disease and synovial fluid tumor necrosis factor, interleukin 6, and prostaglandin E2 values in horses. Am J Vet Res 1993, 54:379.
186. Todhunter PG, Kincaid SA, Todhunter RJ, et al. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. Am J Vet Res 1996, 57:1080.
187. Cornelissen BP, Rijkenhuizen AB, van den Hoogen BM, et al. Experimental model of synovitis/capsulitis in the equine metacarpophalangeal joint. Am J Vet Res 1998, 59:978.
188. Billinghurst RC, Fretz PB, Gordon JR Induction of intraarticular tumour necrosis factor during acute inflammatory responses in equine arthritis. Equine Vet J 1995, 27:208.
189. Yaron I, Meyer FA, Dayer J-M, et al. Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblasts cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 1989, 32:173.
190. Goldring MB, Birkhead J, Sandell LJ, et al. Synergistic regulation of collagen gene expression in human chondrocytes by tumor necrosis factor-+ and interleukin-1β. Ann N Y Acad Sci 1990, 580:536.
191. Brennan FM, Chantry D, Jackson A, et al. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989, 2(8657):244.
192. Jang D, Williams RJ, Wang MX, et al. Staphyloccus aureus stimulates inducible nitric oxide synthase in articular cartilage. Arthritis Rheum 1999, 42:2410.
193. Farrell AJ, Blake DR, Palmer RM, et al. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992, 51:1219.
194. Jarvinen TA H, Moilanen T, Jarvinen TL N, et al. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators Inflamm 1995, 4:107.
195. Pelletier JP, Mineau F, Ranger P, et al. The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritis cartilage degradation. Osteoarthritis Cartilage 1996, 4:77.
196. Hyashi T, Abe E, Yamate T, et al. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 1997, 40:261.
197. Oh M, Fukuda K, Asada S, et al. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite. J Rheumatol 1998, 25:2169.
198. Stefanovic-Racic M, Mollers MO, Miller LA, et al. Nitric oxide and proteoglycan turnover in rabbit articular cartilage. J Orthop Res 1997, 15:442.
199. Cao M, Westerhausen-Larsen A, Niyibizi C, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997, 324:305.
200. Sasaki K, Hattori T, Fujisawa T, et al. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem (Tokyo) 1998, 123:431.
201. Murrell GA C, Jang D, Williams RJ Nitric oxide activated metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995, 206:15.
202. Horton WE, Udo I, Precht P, et al. Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation. In Vitro Cell Dev Biol Anim 1998, 34:378.
203. Bird JL, Wells T, Platt D, et al. IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide. Biochem Biophys Res Commun 1997, 238:81.
204. Connor JR, Manning PT, Settle SL, et al. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995, 273:15.
205. Stefanovich-Racic M, Meyers K, Meschter C, et al. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994, 37:1062.
206. Pelletier JP, Jovanovic D, Fernandes JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998, 41:1275.
207. Pelletier JP, Lascau-Coman V, Jovanovic D, et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999, 26:2002.
208. May SA, Hooke RA, Lees P Identity of the E-series prostaglandin produced by equine chondrocytes and synovial cells in response to a variety of stimuli. Res Vet Sci 1989, 46:54.
209. Tietz CC, Chrisman OD The effect of salicylate and chloroquine on prostaglandin-induced articular damage in the rabbit knee. Clin Orthop 1975, 108:264.
210. Lippiello L, Yamamoto K, Robinson D, et al. Involvement of prostaglandin from rheumatoid synovium and inhibition of articular cartilage metabolism. Arthritis Rheum 1978, 21:909.
211. Robinson DR, Tashijian HJ, Levine L Prostaglandinstimulated bone resorption by rheumatoid synovia: a possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975, 56:1181.
212. Steinberg JJ, Hubbard JR, Sledge CB Chondrocytemediated breakdown of cartilage. J Rheumatol 1993, 20:325.
213. 2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2. Lab Invest 1996, 75:529.
214. 1 inhibit cytokine induced metalloprotease expression in human synovial fibroblasts. Lab Invest 1994, 71:270.
215. Yamada H, Kikuchi T, Nemoto O, et al. Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes. J Rheumatol 1996, 23:1739.
216. DiBattista JA, Dore S, Morin N, et al. Prostaglandin E2 upregulates insulin-like growth factor binding protein-3 expression and synthesis in human articular chondrocytes by a c-AMP-independent pathway: role of calcium and protein kinase A and C. J Cell Biochem 1996, 63:320.
217. Dieppe PA, Harkness JA L, Higgs ER Osteoarthritis. Textbook of pain 1989, Churchill Livingstone, New York. ed 3. P.D. Wall, R. Melzack (Eds.).
218. Moskowitz RW Osteoarthritis: symptoms and signs. Osteoarthritis: diagnosis and management 1984, WB Saunders, Philadelphia. R.W. Moskowitz, D.S. Howell, V.M. Goldberg (Eds.).
219. Richardson DW Degenerative joint disease. Equine medicine and surgery 1991, American Veterinary Publications, Goleta, Calif. ed 4. P.T. Colahan, I.G. Mayhew, A.M. Merritt (Eds.).
220. Wyke B The neurology of joints: a review of general principles. Clin Rheum Dis 1981, 7:223.
221. Dee R The innervation of joints. The joints and synovial fluid 1978, Academic Press, New York. L. Sokoloff (Ed.).
222. Hepplemann B, Pfeffer A, Schaible HG, Schmidt RF Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain 1986, 26:337.
223. Nilsson G Lameness and pathologic changes in the distal joints and phalanges of the standardbred horse. Acta Vet Scand 1973, 44:83.
224. Nilsson B, Olsson SE Radiologic and patho-anatomic changes in the distal joints and the phalanges of the standardbred horse. Acta Vet Scand 1973, 44:1.
225. Kellgren JH Pain in osteoarthritis. J Rheumatol 1983, 9:108.
226. Verschooten F, DeMoor A Subchondral cystic and related lesions affecting the equine pedal bone and stifle. Equine Vet J 1982, 14:47.
227. Jeffcott LB Osteochondrosis in the horse: searching for the key to pathogenesis. Equine Vet J 1991, 23:331.
228. Nixon AJ Osteochondrosis and osteochondritis dissecans of the equine fetlock. Comp Cont Educ Pract Vet 1990, 12:1463.
229. Lawrence JS, Bremner JM, Bier F Osteo-arthrosis: prevalence in the population and relationship between symptoms and x-ray changes. Ann Rheum Dis 1966, 25:1.
230. Cobb S, Merchant WR, Rubin T The relation of symptoms to osteoarthritis. J Chronic Dis 1957, 5:197.
231. Arnoldi CC, Linderholm H, Mussbichler M Venous engorgement and intraosseous hypertension in osteoarthritis of the hip. J Bone Joint Surg Br 1972, 54:409.
232. Stolk PWTH, Firth EC Intra-osseous pressure of the equine third metatarsal bone. Cornell Vet 1988, 78:191.
233. Rodeo SA, Hannafin JA, Tom J, et al. Immunolocalization of cytokines and their receptors in adhesive capsulitis of the shoulder. J Orthop Res 1997, 15:427.
234. Morita Y, Kashihara N, Yamamura M, et al. Inhibition of rheumatoid synovial fibroblast proliferation by antisense oligonucleotides targeting proliferating cell nuclear antigen messenger RNA. Arthritis Rheum 1997, 40:1292.
235. Katayama I, Nishioka K Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. J Dermatol Sci 1997, 15:201.
236. Simpkin PA Synovial physiology. Arthritis and allied conditions: a textbook of rheumatology 1997, 1. Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
237. Tulamo RM, Houttu J, Tupamaki A, et al. Hyaluronate and large molecular weight proteoglycans in synovial fluid from horses with various arthritides. Am J Vet Res 1996, 57:932.
238. Saari H, Konttinen YT, Tulamo RM, et al. Concentration and degree of polymerization of hyaluronate in equine synovial fluid. Am J Vet Res 1989, 50:2060.
239. Tew WP, Hotchkiss RN Synovial fluid analysis and equine joint disorders. Equine Vet Sci 1981, 1:163.
240. White KK, Hodgson DR, Hancock D, et al. Changes in equine carpal joint synovial fluid in response to the injection of two local anesthetic agents. Cornell Vet 1989, 79:25.
241. Van Pelt RW Interpretation of synovial fluid findings in the horse. J Am Vet Med Assoc 1974, 165:91.
242. Bertone AL, McIlwraith CW, Powers B, et al. Effects of four antimicrobial lavage solutions on the tarsocrural joint of horses. Vet Surg 1986, 5:305.
243. Muttini A, Petrizzi L, Tinti A, et al. Synovial fluid parameters in normal and osteochondritic hocks of horses with open physis. Boll Soc Ital Biol Sper 1994, 70:337.
244. Lloyd KC, Stover SM, Pascoe JR, et al. Effect of gentamicin sulfate and sodium bicarbonate on the synovium of clinically normal equine antebrachiocarpal joints. Am J Vet Res 1988, 49:650.
245. Tulamo RM, Bramlage LR, Gabel AA Sequential clinical and synovial fluid changes associated with acute infectious arthritis in the horse. Equine Vet J 1989, 21:325.
246. Adair HS, Goble DO, Vanhooser S, et al. Evaluation of use of dimethyl sulfoxide for intra-articular lavage in clinically normal horses. Am J Vet Res 1991, 52:333.
247. McIlwraith CW Radiographically silent injuries in joints: an overview and discussion. Proc Am Assoc Equine Pract 1991, 37:785.
248. Whitton RC, Kannegieter NJ, Rose RJ The intercarpal ligaments of the equine midcarpal joint. III. Clinical observations in 32 racing horses with midcarpal joint disease. Vet Surg 1997, 26:374.
249. Ross MW, Nolan PM, Palmer JA, et al. The importance of the metatarsophalangeal joint in standardbred lameness. Proc Am Assoc Equine Pract 1991, 37:741.
250. Swanson TD Degenerative disease of the metacarpophalangeal (fetlock) joint in performance horses. Proc Am Assoc Equine Pract 1988, 34:399.
251. Ross MW Scintigraphic and clinical findings in the standardbred metatarsophalangeal joint: 114 cases (1993-1995). Equine Vet J 1998, 30:131.
252. Bjornsdottir S, Axelsson M, Eksell P, et al. Radiographic and clinical survey of degenerative joint disease in the distal tarsal joints in Icelandic horses. Equine Vet J 2000, 32:268.
253. Dyson SJ Lameness due to pain associated with the distal interphalangeal joint: 45 cases. Equine Vet J 1991, 23:128.
254. Schneider RK, Jenson P, Moore RM Evaluation of cartilage lesions on the medial femoral condyle as a cause of lameness in horses: 11 cases (1988-1994). J Am Vet Med Assoc 1997, 210:1649.
255. Moore RM, Schneider RK Arthroscopic findings in the carpal joints of lame horses without radiographically visible abnormalities: 41 cases (1986-1991). J Am Vet Med Assoc 1995, 206:1741.
256. McIlwraith CW, Yovich JV, Martin GS Arthroscopic surgery for the treatment of osteochondral chip fractures in the equine carpus. J Am Vet Med Assoc 1987, 191:531.
257. Kannegieter NJ, Burbidge HM Correlation between radiographic and arthroscopic findings in the equine carpus. Aust Vet J 1990, 67:132.
258. Danielsson LG, Dymling JF, Heripret G Coxarthrosis in man studied with external counting of 85Sr and 47Ca. Clin Orthop 1963, 31:151.
259. Christensen SB Localization of bone-seeking agents in developing experimentally induced ostoarthritis in the knee joint of the rabbit. Scand J Rheumatol 1983, 12:343.
260. Dieppe P, Cushanghan J, Young P, et al. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993, 52:557.
261. Ball MA, Allen D, Parkes A Surgical treatment of sub-chondral cyst-like lesions in the tibia of an adult pony. J Am Vet Med Assoc 1996, 208:704.
262. Erlich PJ, Seeherman HJ, O'Callaghan MW, et al. Results of bone scintigraphy in horses used for show jumping, hunting or eventing: 141 cases (1988-1994). J Am Vet Med Assoc 1998, 213:1460.
263. Erlich PJ, Dohoo IR, O'Callaghan MW Results of bone scintigraphy in racing standardbred horses: 64 cases (1992-1994). J Am Vet Med Assoc 1999, 215:982.
264. Ulhorn H, Eksell P, Sandgren B, Carlsten J Sclerosis of the third carpal bone: a prospective study of its significance in a group of young standardbred trotters. Acta Vet Scand 2000, 41:51.
265. Peterfy CG, Genant HG Magnetic resonance imaging in arthritis. Arthritis and allied conditions: a textbook of rheumatology 1997, 1. Williams & Wilkins, Baltimore. ed 13. A. Koopman (Ed.).
266. Recht MP, Kramer J, Marelis S, et al. Abnormalities of articular cartilage in the knee: analysis of available MR techniques. Radiology 1993, 187:473.
267. Disler DG, McCauley TR, Wirth CR, et al. Detection of knee hyaline articular cartilage defects using fat-suppressed three-dimensional spoiled gradient-echo MR imaging: comparison with standard MR imaging and correlation with arthroscopy. Am J Roentgenol 1995, 165:377.
268. Martinelli MJ, Kuriashkin IV, Carragher BO, et al. Magnetic resonance imaging of the equine metacarpophalangeal joint: three-dimensional reconstruction and anatomic analysis. Vet Radiol Ultrasound 1997, 38:193.
269. Holcombe SJ, Bertone AL, Biller DS, et al. Magnetic resonance imaging of the equine stifle. Vet Radiol Ultrasound 1995, 36:119.
270. Blaik MA, Hanson RR, Kincaid SA, et al. Low-field magnetic resonance imaging of the equine tarsus: normal anatomy. Vet Radiol Ultrasound 2000, 41:131.
271. Kleiter MK, Kneissl S, Stanek C, et al. Evaluation of magnetic resonance imaging techniques in the equine digit. Vet Radiol Ultrasound 1999, 40:15.
272. Martinelli MJ, Baker GJ, Clarkson RB, et al. Magnetic resonance imaging of degenerative joint disease in a horse: a comparison to other diagnostic techniques. Equine Vet J 1996, 28:410.
273. Choquet P, Sick H, Constantinesco A MRI of the equine digit with a dedicated low-field magnet. Vet Rec 2000, 146:616.
274. Modransky PD, Rantanen NW Diagnostic ultrasound examination of the dorsal aspect of the equine metacarpophalangeal joint. J Equine Vet Sci 1983, 3:56.
275. Steyn P, Schmitz D The sonographic diagnosis of chronic proliferative synovitis in the metacarpophalangeal joints of a horse. Vet Radiol 1989, 30:125.
276. Denoix JM Ultrasonographic examination in the diagnosis of joint disease. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).